ANCA-associated vasculitis trials in United States

In United States 19 Also abroad 97

19 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
Where
Ann Arbor, Aurora, Bethesda, Cleveland, Durham, Northfield, Salt Lake City, The Bronx
Age
6 years and over
People
230 worldwide
Run by
AstraZeneca
See details and how to joinNCT07444567
Phase 1/2Taking people
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Where
Ann Arbor, Charlotte, Dallas, Fairway, Hackensack, Los Angeles, Minneapolis, New York, Plantation, Summit, Syracuse, Tampa
Age
18 years to 75 years
People
240
Run by
Nkarta, Inc.
See details and how to joinNCT06733935
No phaseTaking people
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Where
Bethesda
Age
3 years and over
People
4,000
Run by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
See details and how to joinNCT02257866
Phase 3Taking people
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
Where
Aurora, Cincinnati, Highland Hills
Age
6 years to 17 years
People
14 worldwide
Run by
AstraZeneca
See details and how to joinNCT06512883 · EU 2023-508533-14-00
Phase 1Taking people
Pharmacokinetics Of Emulsified Avacopan Applied By NG Tube
Where
Rochester
Age
18 years and over
People
6
Run by
Mayo Clinic
See details and how to joinNCT07556484
Phase 4Taking people
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Where
Albany, Albuquerque, Anchorage, Atlanta, Aurora, Austin, Baltimore, Beckley, Boca Raton, Boston, Charleston, Cleveland, Columbus, Covina, Dallas, Detroit, East Providence, Fairfax, Fremont, Fresno, Fullerton, Gainesville, Great Neck, Greensboro, Greenville, Iowa City, Jackson, Jacksonville, Lebanon, Lexington, Menifee, Miamisburg, Milwaukee, Minneapolis, Nashville, New Albany, New York, Oklahoma City, Orlando, Philadelphia, Pittsburgh, Portland, Red Oak, Reno, Rochester, Saginaw, Saint Clair Shores, San Francisco, Scottsdale, Searcy, Seattle, Sioux City, Spartanburg, Sterling Heights, Surprise, Tampa, Temple, Torrance, Valencia, Winston-Salem
Age
18 years to 100 years
People
300 worldwide
Run by
Amgen
See details and how to joinNCT06072482
Phase 2/3Taking people
TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
Where
Edison, New York
Age
18 years and over
People
30
Run by
Robert Spiera, MD
See details and how to joinNCT07176546
Phase 1/2Taking people
FT839 in Autoimmune Diseases
Where
Fullerton
Age
18 years to 70 years
People
446
Run by
Fate Therapeutics
See details and how to joinNCT07800871
No phaseTaking people
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
Where
Boston, Cleveland, Denver, Philadelphia, Pittsburgh, Rochester, Salt Lake City, San Diego
People
700 worldwide
Run by
University of Pennsylvania
See details and how to joinNCT00315380
Phase 1/2Taking people
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Where
Cincinnati, St Louis, Washington D.C.
Age
12 years and over
People
50
Run by
Cartesian Therapeutics
See details and how to joinNCT07089121
Phase 2Taking people
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Where
New York
Age
18 years and over
People
80
Run by
NYU Langone Health
See details and how to joinNCT07138898
Phase 1Taking people
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Where
Beverly Hills, Cleveland, Durham, Fullerton, Gainesville, Irvine, Los Angeles, Louisville, Memphis, Miami, Minneapolis, New York, Oklahoma City, Omaha, Philadelphia, San Francisco
Age
12 years to 70 years
People
244 worldwide
Run by
Fate Therapeutics
See details and how to joinNCT06308978
Phase 1Enrolling by invitation
A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease
Where
Buffalo, Redwood City
Age
18 years to 80 years
People
180
Run by
Adicet Therapeutics
See details and how to joinNCT06375993
No phaseTaking people
Vasculitis Pregnancy Registry
Where
Tampa
Age
18 years to 50 years
People
100
Run by
University of Pennsylvania
See details and how to joinNCT02593565
No phaseTaking people
One-Time DNA Study for Vasculitis
Where
Ann Arbor, Chicago, Cleveland, Kansas City, Los Angeles, New York, Philadelphia, Pittsburgh, Rochester, Salt Lake City, San Francisco
Age
7 years and over
People
1,000 worldwide
Run by
University of Pennsylvania
See details and how to joinNCT01241305
No phaseTaking people
VCRC Tissue Repository
Where
Boston, Cleveland, Philadelphia, Pittsburgh, Salt Lake City
People
1,000 worldwide
Run by
University of Pennsylvania
See details and how to joinNCT02967068
No phaseTaking people
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
Where
Boston, Charlottesville, Cleveland, Los Angeles, Philadelphia, Portland, Rochester, Salt Lake City
Age
5 years and over
People
50 worldwide
Run by
Peter Merkel
See details and how to joinNCT03004326
Phase 1Taking people
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
Where
Plantation
Age
18 years and over
People
30
Run by
IRIS Research and Development, LLC
See details and how to joinNCT06581562
Phase 2Taking people
Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
Where
Denver
Age
18 years and over
People
10
Run by
National Jewish Health
See details and how to joinNCT02947945